Differences
This shows you the differences between two versions of the page.
Both sides previous revisionPrevious revisionNext revision | Previous revisionBoth sides next revision | ||
covid-19:treatments:drug_therapies:hydroxychloroquine [2022/01/05 08:22] kalev [Links to be Sorted] | covid-19:treatments:drug_therapies:hydroxychloroquine [2022/10/05 01:02] (current) mathew | ||
---|---|---|---|
Line 12: | Line 12: | ||
==== Prior Research ==== | ==== Prior Research ==== | ||
Since shortly after the first [[: | Since shortly after the first [[: | ||
+ | * In 2005, researcher Martin Vincent and colleagues noted that chloroquine is a potent inhibitor of SARS coronavirus infection and spread.((August 22, 2005 | Vincent et al | [[:Virology Journal]] | [[https:// | ||
- | ==== Antiviral Properties Research ==== | + | ==== Antiviral Properties Research |
+ | * Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture((September 14, 2022 | Zixuan Yuan et al | Nature (journal) | Hydroxychloroquine blocks SARS-CoV-2 entry into the endocytic pathway in mammalian cell culture | [[https:// | ||
===== Evidence for Prophylaxis ===== | ===== Evidence for Prophylaxis ===== |